127 related articles for article (PubMed ID: 15103034)
1. Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis.
Tutar E; Ekici F; Naçar N; Arici S; Atalay S
Rheumatology (Oxford); 2004 May; 43(5):674-5. PubMed ID: 15103034
[No Abstract] [Full Text] [Related]
2. Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.
Armbrust W; Kamphuis SS; Wolfs TW; Fiselier TJ; Nikkels PG; Kuis W; Wulffraat NM
Rheumatology (Oxford); 2004 Apr; 43(4):527-9. PubMed ID: 15024141
[No Abstract] [Full Text] [Related]
3. Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis.
Pipitone MA; Adams B; Sheth A; Graham TB
J Am Acad Dermatol; 2005 Apr; 52(4):719-20. PubMed ID: 15793541
[No Abstract] [Full Text] [Related]
4. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
[No Abstract] [Full Text] [Related]
5. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis and treatment with infliximab.
Myers A; Clark J; Foster H
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859881
[No Abstract] [Full Text] [Related]
7. Urticarial vasculitis due do infliximab.
Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
[No Abstract] [Full Text] [Related]
8. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis?
Prendiville JS; Tucker LB; Cabral DA; Crawford RI
Pediatr Dermatol; 2004; 21(5):580-8. PubMed ID: 15461768
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
Ruperto N; Lovell DJ; Cuttica R; Wilkinson N; Woo P; Espada G; Wouters C; Silverman ED; Balogh Z; Henrickson M; Apaz MT; Baildam E; Fasth A; Gerloni V; Lahdenne P; Prieur AM; Ravelli A; Saurenmann RK; Gamir ML; Wulffraat N; Marodi L; Petty RE; Joos R; Zulian F; McCurdy D; Myones BL; Nagy K; Reuman P; Szer I; Travers S; Beutler A; Keenan G; Clark J; Visvanathan S; Fasanmade A; Raychaudhuri A; Mendelsohn A; Martini A; Giannini EH; ;
Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439
[TBL] [Abstract][Full Text] [Related]
10. Psoriasiform and pustular eruption induced by etanercept and infliximab.
Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
[No Abstract] [Full Text] [Related]
11. Eczematous drug eruption after infliximab.
Dumont-Berset M; Laffitte E; Gerber C; Dudler J; Panizzon RG
Br J Dermatol; 2004 Dec; 151(6):1272-3. PubMed ID: 15606528
[No Abstract] [Full Text] [Related]
12. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
Balci DD; Peker E; Duran N; Dogramaci CA
Cutan Ocul Toxicol; 2009; 28(1):45-7. PubMed ID: 19514926
[TBL] [Abstract][Full Text] [Related]
13. Juvenile idiopathic arthritis: some progress but still many uncertainties.
Prescrire Int; 2007 Aug; 16(90):168. PubMed ID: 17724846
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
[TBL] [Abstract][Full Text] [Related]
15. [Persistent inflammation of the nasal dorsum in a patient with rheumatoid arthritis treated with infliximab].
García-Castro JM; Javier-Martínez R; Cáliz-Cáliz R; García-Sánchez A
Enferm Infecc Microbiol Clin; 2012 Jan; 30(1):40-2. PubMed ID: 21903302
[No Abstract] [Full Text] [Related]
16. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
[No Abstract] [Full Text] [Related]
17. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report.
Kasher-Meron M; Uziel Y; Amital H
Rheumatology (Oxford); 2009 Apr; 48(4):445-6. PubMed ID: 19164423
[No Abstract] [Full Text] [Related]
19. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
[TBL] [Abstract][Full Text] [Related]
20. Retrospective case review of pediatric patients with uveitis treated with infliximab.
Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
